Pediatric patients with malignant brain tumor treated at children's hospitals: association with fewer unplanned

Kristie Q Liu1, Shivani D Rangwala1, Talia A Wenger1

  • 11Department of Neurological Surgery, Keck School of Medicine, University of Southern California, Los Angeles; and.

Insights

Treatment at children's hospitals significantly reduces 30-day readmission rates for pediatric brain tumor patients. This study highlights the benefit of specialized pediatric care for improving outcomes in childhood cancer survivors.

Area of Science:

  • Pediatric Oncology
  • Health Services Research
  • Neurosurgery

Background:

  • Pediatric primary brain tumors are a leading cause of childhood cancer mortality.
  • Specialized multidisciplinary care is recommended for optimal outcomes in pediatric cancer patients.
  • Hospital readmission rates are a key metric for assessing patient outcomes and healthcare quality.

Purpose of the Study:

  • To investigate the impact of treatment at a designated children's hospital versus a non-children's hospital on readmission rates for pediatric patients undergoing craniotomy for brain tumor resection.
  • To analyze national database records to evaluate the association between hospital designation and patient outcomes.

Main Methods:

  • Retrospective analysis of the Nationwide Readmissions Database (2010-2018).
  • Inclusion of 4003 patients who underwent craniotomy for brain tumor resection.
  • Univariate and multivariate regression analyses to assess the association with 30-day readmissions, mortality, and length of stay.

Main Results:

  • Patients treated at children's hospitals (31.4% of cases) had a significantly lower likelihood of 30-day readmission (OR 0.68, p = 0.036).
  • No significant difference in index mortality was observed between children's and non-children's hospitals.
  • The study provides national estimates on the impact of hospital designation on outcomes.

Conclusions:

  • Treatment at children's hospitals is associated with decreased 30-day readmission rates for pediatric brain tumor patients.
  • No difference in mortality suggests that specialized care may improve recovery and reduce complications.
  • Further prospective studies are recommended to confirm these findings and identify specific factors contributing to better outcomes.
Abstract